One of the scientists behind the Oxford/AstraZeneca Covid-19 vaccine has defended a decision to make profits on new supply deals, as the partnership announced that more than 2bn doses had been delivered.
牛津 /阿斯利康(Oxford/AstraZeneca)新冠疫苗研发团队的一名科学家为从新的供应协议中获利的决定进行了辩护。目前牛津 /阿斯利康宣布已交付逾20亿剂疫苗。
您已阅读8%（289字），剩余92%（3139字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。